Indivior Pharmaceuticals, Inc. (INDV) ROI
- 2026-06-30: ROI 127.24%.
- 2026-03-31: ROI 73.39%.
- 2025-12-31: ROI 94.57%.
- 2025-09-30: ROI 111.30%.
Complete source-backed roi history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | 127.24% |
| 2026-03-31 | 73.39% |
| 2025-12-31 | 94.57% |
| 2025-09-30 | 111.30% |
| 2025-06-30 | 156.52% |
| 2025-03-31 | -15.91% |
| 2024-12-31 | -175.00% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | 95.02% |
| 2024-12-31 | -175.00% |
| 2023-12-31 | -225.00% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |